Tag Archives: NASDAQ:CFMS

ConforMIS Got Some Good News

In a report released today, Kyle Rose from Canaccord Genuity upgraded ConforMIS (NASDAQ: CFMS) to Buy. The company’s shares closed yesterday at $1.36, close to its 52-week low of $1.15. According to TipRanks.com, Rose is a 4-star analyst with an

Analysts Offer Insights on Healthcare Companies: ConforMIS (NASDAQ: CFMS), BeiGene Ltd (NASDAQ: BGNE) and Perrigo Company plc (NYSE: PRGO)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on ConforMIS (NASDAQ: CFMS), BeiGene Ltd (NASDAQ: BGNE) and Perrigo Company plc (NYSE: PRGO). ConforMIS (NASDAQ: CFMS) In a report released yesterday, Kyle Rose

The CFO of ConforMIS (NASDAQ: CFMS) is Selling Shares

Yesterday, the CFO of ConforMIS (NASDAQ: CFMS), WEINER PAUL, sold shares of CFMS for $3,449. In addition to WEINER PAUL, 3 other CFMS executives reported Sell trades in the last month. The company has a one-year high of $8.61 and

Analysts Offer Insights on Healthcare Companies: ConforMIS (NASDAQ: CFMS), Amgen Inc (NASDAQ: AMGN) and Dexcom (NASDAQ: DXCM)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on ConforMIS (NASDAQ: CFMS), Amgen Inc (NASDAQ: AMGN) and Dexcom (NASDAQ: DXCM). ConforMIS (NASDAQ: CFMS) In a report released yesterday, Ryan Zimmerman from BTIG

The CTO of ConforMIS (NASDAQ: CFMS) is Selling Shares

Yesterday, the CTO of ConforMIS (NASDAQ: CFMS), Steines Daniel, sold shares of CFMS for $12.44K. In addition to Steines Daniel, 2 other CFMS executives reported Sell trades in the last month. The company has a one-year high of $8.91 and

BTIG Thinks ConforMIS’s Stock is Going to Recover

In a report released today, Ryan Zimmerman from BTIG upgraded ConforMIS (NASDAQ: CFMS) to Buy. The company’s shares opened today at $2.29, close to its 52-week low of $2.22. According to TipRanks.com, Zimmerman is a 3-star analyst with an average